The estimated Net Worth of Kevin C. Smith is at least 1 百万$ dollars as of 17 August 2020. Mr. Smith owns over 1,529 units of Wright Medical NV stock worth over 811,109$ and over the last 6 years he sold WMGI stock worth over 190,710$. In addition, he makes 0$ as Senior Vice President、 Quality and Regulatory at Wright Medical NV.
Kevin has made over 8 trades of the Wright Medical NV stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 1,529 units of WMGI stock worth 46,053$ on 17 August 2020.
The largest trade he's ever made was selling 1,529 units of Wright Medical NV stock on 17 August 2020 worth over 46,053$. On average, Kevin trades about 538 units every 62 days since 2018. As of 17 August 2020 he still owns at least 27,055 units of Wright Medical NV stock.
You can see the complete history of Mr. Smith stock trades at the bottom of the page.
Kevin C. Smith serves as Senior Vice President, Quality and Regulatory of the Company. From May 2012 to February 2018, Mr. Smith served as our Vice President, Global Quality and Regulatory Affairs. Prior to joining Wright, Mr. Smith served as Corporate Director, Quality Systems for Boston Scientific Corporation, a global medical technology company, from December 2001 to May 2012.
Kevin Smith is 60, he's been the Senior Vice President、 Quality and Regulatory of Wright Medical NV since 2018. There are 8 older and 14 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
Kevin's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Over the last 9 years, insiders at Wright Medical NV have traded over 526,674,381$ worth of Wright Medical NV stock and bought 118,654 units worth 2,654,459$ . The most active insiders traders include Sean Carney、Elizabeth H Weatherman、Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of 4,402,563$. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth 28,644$.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: